Retatrutide, by Soma Pharmaceuticals , represents a promising advance in weight management . This innovative compound combines incretin receptor activity with gut-derived receptor activation , demonstrating substantial efficacy in clinical studies for weight improvement. Researchers believe the drug is expected to offer a different option for patie